CORDIS
EU research results

CORDIS

English EN
Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing

Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing

Objective

Colorectal cancer (CRC) is one of the leading causes of death by cancer, which is largely associated to metastatic spread of the disease. Progress to develop efficient therapies, including immunotherapies, for patients with metastatic CRC has been hampered by the lack of preclinical models to study late stage CRC in an immunocompetent background. We have developed the first genetic mouse model of advanced CRC in immunocompetent mice. This model is based in a biobank of mouse tumor organoids (MTOs) derived from tumors arising in compound mice bearing genetic alterations in 4 driver genes associated to CRC progression: WNT, EGFR, p53, and TGF-beta signaling. We have demonstrated that these MTOs represent an invaluable tool for basic and pre-clinical research in CRC, in particular to test immunotherapies (Tauriello et al., Nature 2018).

Despite its potential, the MTO biobank has limitations for translational research. They were generated as academic tools which has prevented their use in technology transfer projects and collaborations with pharmaceutical companies. In addition, they do not cover all the different CRC subtypes. We propose to create an improved and more complete second-generation MTO biobank that a) recreates the described pre-clinical model of advanced CRC, b) extends the model collection to other subsets of CRCs by means of genome editing tools and c) grants freedom to operate. These newly generated MTOs will represent unique tools ready to be licenced and exploited in strategic public-private collaborations with the final goal to aid in the development of new drugs to treat advanced CRC patients.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Host institution

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

Address

Carrer Baldiri Reixac 10-12 Parc Scientific De Barcelona
08028 Barcelona

Spain

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 149 955

Beneficiaries (1)

Sort alphabetically

Sort by EU Contribution

Expand all

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

Spain

EU Contribution

€ 149 955

Project information

Grant agreement ID: 825836

Status

Ongoing project

  • Start date

    1 December 2018

  • End date

    31 May 2020

Funded under:

H2020-EU.1.1.

  • Overall budget:

    € 149 955

  • EU contribution

    € 149 955

Hosted by:

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)

Spain